The company's most advanced product, Colofast, is a non-invasive screening signature for colorectal cancer and advanced adenoma diagnosis in blood. Amadix's team consists of industry veterans with expertise in oncology diagnostics, pharmaceuticals, biotechnology, and intellectual property. The company also has independent board members with international profiles and experience in oncology and diagnostics. Amadix's mission is to extend people's lives by developing disruptive technologies for early cancer detection in blood, avoiding the complications of existing invasive procedures.